{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"Adverse Events of Special Interest (AESI) will be determined for each subject as binary variables indicating whether or not they experienced a protocol defined AESI, including bleeding, bruising, skin infection, edema, dry skin, urticaria, pruritus, rash, pain or flushing at the acupuncture site, or dizziness, syncope, fatigue, or hyperhidrosis.","groups":[{"description":"Acupuncture: 12 acupuncture sessions over 10 weeks","id":"OG000","title":"Acupuncture"},{"description":"Standard of Care CIPN management: Investigator directed standard of care management of CIPN","id":"OG001","title":"Standard of Care"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Enrolled participants on the acupuncture arm","reportingStatus":"POSTED","timeFrame":"approx. 10 weeks","title":"Adverse Events of Special Interest","type":"OTHER_PRE_SPECIFIED","unitOfMeasure":"Participants"}